SynBioBeta Speaker
Samuel Levin
Neion Bio
Co-Founder & CTO
Sam Levin is a biotech entrepreneur and accomplished scientific leader with 15 years of research experience and over a decade of leading complex, multidisciplinary scientific enterprises. He has deep expertise at the intersection of genetic engineering, automation, and complex systems biology. He has numerous peer-reviewed publications in leading journals and serves as an advisor to multiple companies and research organizations. His work has been featured in top outlets including The New York Times, Forbes, and the Discovery Channel. Prior to Neion Bio, Sam was the Co-Founder and CEO of Melonfrost, where he built the world’s most high-throughput automated bioreactor system, integrated with proprietary machine learning algorithms to direct microbial evolution for industrial biotechnology. Sam holds a PhD and Bachelor’s Degree in the field of evolutionary biology from the University of Oxford.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Samuel
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
